A Study to Evaluate the Safety of Hydronidone Capsules in Patients With Liver Fibrosis

Clinical trial NCT07364448 · COMPLETED

Trial details

NCT number: NCT07364448
Sponsor: Beijing Continent Pharmaceutical Co, Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis B With Hepatic Fibrosis

Start date: 2026-03-12
Primary completion: 2026-06-22
Enrollment: 411

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.